Tisagenlecleucel, sold under the brand name Kymriah was the first gene therapy approved by the FDA on 30 August 2017....
Hematology
In February 2022, the Food and Drug Administration (FDA) approved nivolumab with platinum-doublet chemotherapy for adult patients with resectable non-small...
In February 2022, the Food and Drug Administration (FDA) approved ciltacabtagene autoleucel for Janssen Biotech for the treatment of adult...
Several indications and molecules were approved in December by FDA including the following: Abatacept for the prophylaxis of acute graft...
Several indications and molecules were approved in August by FDA including the following: 1- Lenvatinib plus pembrolizumab for first-line treatment...
Several indications and molecules were approved in July by FDA including the following: Asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component...
Several molecules and indications were approved in April 2021 by FDA. Among the key approvals are the following: Accelerated approval...
Congenital afibrinogenemia or familial afibrinogenemia is a rare, genetically inherited blood fibrinogen disorder in which the blood does not clot normally due...
In September, the FDA approved 2 new medications in the oncology & hematology category. Pralsetinib was approved for adult patients...
Sickle cell disease is a group of inherited and lifelong health conditions that affect the red blood cells. The most...
